MedTech News
Pulse wins IDE approval
Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.
Cancer cells steal mitochondria from nerve cells in order to boost their energy
The finding opens a new path for cancer treatment.
TruLeaf Implanted First-of-its-Kind Heart Valve via Catheter Only
The current step represents a major proof of concept in humans for TruLeaf’s innovative technology aimed at transcatheter replacement of the mitral and tricuspid valves
Using deep learning for precision cancer therapy
Nearly 50 new cancer therapies are approved every year. This is good news. “But for patients and their treating physicians, it is becoming increasingly difficult to keep track and to select the treatment methods from which the people affected—each with their very individual tumor characteristics—will benefit the most,” says Dr. Altuna Akalin, head of the Bioinformatics and Omics Data Science technology platform at the Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB).
New study links blood proteins to Alzheimer’s disease and memory loss
Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory.
Antigen amplification strategy shows promise for more precise next-generation immunotherapies
Tumor immunotherapies, especially those leveraging T-cells to identify and eliminate cancer cells, represent a major breakthrough in cancer treatment. However, many tumor-associated antigens are not expressed at a high enough density on the cancer cell surface to effectively activate T-cells, and these antigens are often present at low levels in normal tissues, leading to poor treatment specificity and potential off-target toxic side effects.
Haag-Streit USA announces US launch of Elara 900 and Refractor 900
MASON, Ohio, Sept. 12, 2025 /PRNewswire/ — Haag-Streit USA, a leading manufacturer and distributor of ophthalmic diagnostic devices, surgical microscopes, and virtual reality-based medical simulators, is proud to announce the launch of two new innovations: the Elara 900 and the Refractor 900. Both products will make their international debut at ESCRS 2025 in Copenhagen and their US debut at the American Academy of Ophthalmology (AAO) annual meeting in October.
Pulnovo earns duo of FDA IDE nods for hypertension treatment
Pulnovo Medical announced today that it received two FDA investigational device exemption (IDE) approvals for its technology.